Skip to main content
DOWNLOAD THE FULL REPORT
Privacy Policy
By submitting this form, you confirm that you agree to the storing and processing of your personal data by Creatio as described in the Privacy Policy.

Strategic insights for digital & IT leaders

on how organizations that have adopted or considering adopting low-code/no-code unlock digital transformation success

Download the research
DOWNLOAD THE FULL REPORT
Privacy Policy
By submitting this form, you confirm that you agree to the storing and processing of your personal data by Creatio as described in the Privacy Policy.

KEY HIGHLIGHTS

59%

of pharma industry leaders plan to continue their ongoing transformation

95%

of respondents say that low-code/no-code is faster than traditional development

1.7 billion

knowledge workers are looking for a way to automate their processes

</>

Low-code/no-code is adopted primarily for accelerated time to market and reduced app development cost

Low-code/no-code technology is key enabler of digital transformation in the pharma industry

</>

Low-code/no-code is adopted primarily for accelerated time to market and reduced app development cost

Low-code/no-code technology is key enabler of digital transformation in the pharma industry

Rebecca Wettemann,
Tech industry analyst and thought leader,
CEO at Valoir, CRM expert

As Creatio’s research shows, companies are seeking to continue or accelerate digital transformation and automation in 2021. Beyond escaping the initial IT constraints, low-code/no-code technologies enable them to put tools in the hands of the business users who are best able to identify and enable process improvements and innovations, and continue to adapt them over time.

I applaud Creatio’s efforts to be a thought leader in the low-code/no-code space. This research highlights the company’s understanding of the innovations and challenges in the low-code/no-code space as well as its long history of providing no-code/low-code capabilities to business users around the world.

Download your complimentary copy of the global market research to get strategic insights

Download the researchDownload the research

From December 2020 to January 2021, Creatio surveyed senior level decision makers in the pharmaceutical industry from varying geographies to gain an inside look at the goals and challenges of digital transformation and process automation.

Read about how ready organizations are to adopt low-code/no-code technologies as part of their transformation strategy and why.

DIGITAL TRANSFROMATION IN THE PHARMACEUTICAL INDUSTRY 

  • The driving forces behind the digital transformation: introducing new products and services at neck-breaking speed
  • Key barriers to accelerating digital transformation
  • How the increased demand for products shapes the pharmaceutical industry after COVID-19

WINNING WITH LOW-CODE/NO-CODE

  • How pharma industry leaders enable process automation with no-code/low-code tools
  • New ways of meeting businesses’ needs and supporting customers in unprecedented times
  • Technology trends for pharma: machine learning, AI and big data analytics

ENABLING ACCELERATION WITH LOW-CODE/NO-CODE TOOLS

  • An increased focus on digital innovation and customer-facing apps
  • Digitizing the companies’ core capabilities to influence an organization’s bottom line and KPIs
  • How low-code/no-code development approach helps organizations automate their workflows with fewer resources and at light speed

THE FUTURE OUTLOOK

  • How remote work and anywhere operations will continue to impact pharma businesses
  • An increased influence of new technologies on the patients’ health journeys
  • A new culture of citizen development: why every successful organization is now a software company

To find out more about digital transformation trends

and the future of low-code/no-code

Download the researchDownload the research

Creatio Low-code platform
for process management and CRM

Try it free